CD4+ T cells were significantly elevated, while CD8+ T cells were significantly diminished in MS, as reflected by frequencies (Figure 1D) and CD4+/CD8+ T‐cell ratios (Figure 1E). This evidence concerns the gene CD8A and myeloid sarcoma.